Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
Ali
Ridvan
R
Beksac
Meral
M
Ozkalemkas
Fahir
F
Ozkocaman
Vildan
V
Ozkan
Atilla
A
Ozcelik
Tulay
T
Tunali
Ahmet
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib